Recent News

• 06.04.2025 - Jefferies Global Healthcare Conference
• 06.04.2025 - Jefferies Global Healthcare Conference
• 05.28.2025 - Kyverna Therapeutics to Present at the Jefferies Global Healthcare Conference
• 05.28.2025 - Kyverna Therapeutics to Present at the Jefferies Global Healthcare Conference
• 05.13.2025 - Kyverna Therapeutics Provides Business Update and Reports First Quarter 2025 Financial Results
• 05.13.2025 - Kyverna Therapeutics Provides Business Update and Reports First Quarter 2025 Financial Results
• 03.27.2025 - Kyverna Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Recent Filings

• 05.13.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.13.2025 - EX-99.1 EX-99.1
• 05.13.2025 - 8-K Current report
• 04.15.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.15.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.15.2025 - EFFECT Notice of Effectiveness
• 04.15.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.15.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 04.14.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.14.2025 - DEF 14A Other definitive proxy statements